CymitQuimica logo

Eliglustat

CAS:

Ref. 3D-FD158477

25mg
254.00€
50mg
382.00€
100mg
544.00€
250mg
889.00€
500mg
1,366.00€
Eliglustat
Biosynth

Product Information

Name:Eliglustat
Synonyms:
  • N-[(1R,2R)-2-(2,3-Dihydro-1,4-benzodioxin-6-yl)-2-hydroxy-1-(1-pyrrolidinylmethyl)ethyl]octanamide
Brand:Biosynth
Description:Eliglustat is an oral medication used as a substrate reduction therapy for Gaucher disease type 1, which is an inherited lysosomal storage disorder. This product is a small-molecule inhibitor derived via chemical synthesis. Its primary mode of action involves the selective inhibition of glucosylceramide synthase, an enzyme responsible for the first committed step in glycosphingolipid biosynthesis. By reducing the production of glucosylceramide, eliglustat decreases the substrate accumulation that contributes to the pathophysiology of Gaucher disease.
Notice:Our products are intended for lab use only. For any other use, please contact us.

Chemical properties

Molecular weight:404.54 g/mol
Formula:C23H36N2O4
Purity:Min. 97 Area-%
Color/Form:White Powder

Technical inquiry about: Eliglustat

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
◻️
CYMIT QUÍMICA, S.L. as responsible for the treatment will treat your data in order to respond to your queries or requests. You can access, rectify and delete your data, as well as exercise other rights by consulting the additional and detailed information on data protection in our Web Privacy Policy.
* Mandatory fields.